Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN LISPRO for Hyperkalaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where INSULIN LISPRO was used for Hyperkalaemia.

Most Reported Side Effects for INSULIN LISPRO

Side Effect Reports % Deaths Hosp.
Blood glucose increased 31,969 39.9% 36 3,364
Incorrect dose administered 8,318 10.4% 5 476
Blood glucose decreased 6,439 8.0% 17 1,098
Drug ineffective 5,411 6.8% 14 670
Visual impairment 4,654 5.8% 5 430
Underdose 3,156 3.9% 1 96
Drug dose omission 3,063 3.8% 1 277
Glycosylated haemoglobin increased 2,482 3.1% 9 396
Blood glucose abnormal 2,460 3.1% 12 465
Malaise 2,204 2.8% 20 384
Hypoglycaemia 2,141 2.7% 65 1,028
Injection site pain 2,031 2.5% 2 138
Accidental underdose 1,882 2.4% 0 90
Wrong technique in product usage process 1,816 2.3% 3 139
Cataract 1,676 2.1% 0 263

Other Indications for INSULIN LISPRO

Product used for unknown indication (28,683) Type 2 diabetes mellitus (16,871) Diabetes mellitus (16,084) Type 1 diabetes mellitus (9,401) Gestational diabetes (502) Blood glucose increased (295) Latent autoimmune diabetes in adults (119) Blood glucose abnormal (94) Insulin-requiring type 2 diabetes mellitus (92) Diabetes mellitus inadequate control (72)

Other Drugs Used for Hyperkalaemia

PATIROMER (8,578) SODIUM ZIRCONIUM CYCLOSILICATE (762) SODIUM POLYSTYRENE SULFONATE (303) CALCIUM (97) INSULIN NOS (84) ALBUTEROL (83) CALCIUM POLYSTYRENE SULFONATE (73) FUROSEMIDE (63) SODIUM BICARBONATE (43) DEXTROSE (38)

Related Pages

INSULIN LISPRO Full Profile All Hyperkalaemia Drugs INSULIN LISPRO Demographics INSULIN LISPRO Timeline